XML 29 R18.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
COMMITMENTS AND CONTINGENCIES (Details Narrative)
$ in Thousands
 1 Months Ended 3 Months Ended 12 Months Ended
Feb. 24, 2024
USD ($)
Jan. 26, 2024
USD ($)
shares
Oct. 06, 2022
USD ($)
Oct. 03, 2022
Mar. 31, 2021
USD ($)
Apr. 28, 2019
USD ($)
Jan. 04, 2018
USD ($)
shares
Jun. 30, 2012
Mar. 31, 2024
USD ($)
shares
Dec. 31, 2023
USD ($)
Mar. 31, 2024
ILS (₪)
Feb. 24, 2024
ILS (₪)
Dec. 11, 2022
USD ($)
Dec. 11, 2022
ILS (₪)
Jun. 10, 2021
USD ($)
Loss Contingencies [Line Items]                              
Net sales royalty percenatge                 3.00%            
Gross proceeds from cash fee percentage       7.00%                      
Gross proceeds from management fee percentage       1.00%                      
Stock issued during period, value, new issues [1]                 $ 2,397            
Litigation settlement amount   $ 2,154                          
Settlement agreement liability                   $ 2,211          
Insurance recoverable                   1,335          
Settlement amount recovery                   1,100          
Legal expense                   235          
Non operating loss on legal settlement                   $ 1,111          
Joseph Mona [Member]                              
Loss Contingencies [Line Items]                              
Purchase price of plaintiffs         $ 485                    
Chief Executive Officer [Member]                              
Loss Contingencies [Line Items]                              
Contigent bonus $ 298                            
Contigent description The first 50% of the CEO’s contingent bonus ($149) is payable upon the Company raising at least $3,000 in new funds by June 30, 2024. The remaining 50% ($149), payable upon the Company raising at least $6,000 in new funds by September 30, 2024 (cumulative, so if $3,000 is not raised by June 30, 2024 but the full $6,000 is raised by September 30, 2024, the full amount is payable).                            
Other Executives [Member]                              
Loss Contingencies [Line Items]                              
Contigent bonus $ 60                     ₪ 230,736      
Contigent description which is payable upon the Company raising at least $3,000 in new funds by September 30, 2024.                            
Common Stock [Member]                              
Loss Contingencies [Line Items]                              
Stock issued during period, value, new issues [1]                 $ 17            
Number of share issued | shares [1]                 1,685,682            
Device [Member]                              
Loss Contingencies [Line Items]                              
Royalties percentage     3.00%                        
Integrated Product [Member]                              
Loss Contingencies [Line Items]                              
Royalties percentage     1.50%                        
Securities Purchase Agreement [Member]                              
Loss Contingencies [Line Items]                              
Purchase price of plaintiffs                 $ 6,750            
Litigation Settlement [Member]                              
Loss Contingencies [Line Items]                              
Payment for litigation settlement   $ 1,100             1,100            
Restricted common shares issued for legal settlement | shares   1,005,965                          
Insurance recovery amount                 $ 1,335            
Litigation Settlement [Member] | Common Stock [Member]                              
Loss Contingencies [Line Items]                              
Number of share issued | shares                 1,005,965            
Israeli Innovation Authority [Member]                              
Loss Contingencies [Line Items]                              
Grants receivable                 $ 74       $ 83 ₪ 300,000  
Additional grant receivable                 $ 447   ₪ 1,620,000        
Israeli Innovation Authority [Member] | Minimum [Member]                              
Loss Contingencies [Line Items]                              
Net sales royalty percenatge                 3.00%            
Israeli Innovation Authority [Member] | Maximum [Member]                              
Loss Contingencies [Line Items]                              
Net sales royalty percenatge                 5.00%            
Israeli Innovation Authority [Member] | CardioSert Ltd [Member]                              
Loss Contingencies [Line Items]                              
Repayment of government grants             $ 530                
Israeli Innovation Authority [Member] | Nitiloop [Member]                              
Loss Contingencies [Line Items]                              
Repayment of government grants     $ 925                        
Ministry Of Economy [Member]                              
Loss Contingencies [Line Items]                              
Grants receivable                 $ 50            
Technion Research and Development Foundation Limited [Member] | Minimum [Member]                              
Loss Contingencies [Line Items]                              
Net sales royalty percenatge               1.50%              
Technion Research and Development Foundation Limited [Member] | Maximum [Member]                              
Loss Contingencies [Line Items]                              
Net sales royalty percenatge               3.00%              
CardioSert Ltd [Member] | Technology [Member]                              
Loss Contingencies [Line Items]                              
Payment to acquire intangible assets             $ 300                
Number of common shares issued for acquisition | shares             6,738                
Number of common shares issued for acquisition, value             $ 74                
H.C. Wainwright & Co. LLC [Member]                              
Loss Contingencies [Line Items]                              
Warrant issued, descriptions       The Company has also agreed to issue to Wainwright or its designees preferred investment options upon the closing of such offerings, equal to five (5.0%) percent of the aggregate number of such shares of common stock in such offerings, including upon exercise for cash of any warrants issued to investors in such offering.                      
H.C. Wainwright & Co. LLC [Member] | At-the-Market Offering Agreement [Member]                              
Loss Contingencies [Line Items]                              
Offering costs                             $ 10,000
Stock issued during period, value, new issues     $ 8,000                        
Alliance Investment Management, Ltd. [Member]                              
Loss Contingencies [Line Items]                              
Litigation settlement           $ 468                  
2013 through March 31, 2024 [Member] | Israeli Innovation Authority [Member]                              
Loss Contingencies [Line Items]                              
Revenue grants received                 $ 1,878            
[1] Net of issuance costs in the amount of $333.